Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

CG Oncology (CGON) Other Non Operating Income: 2023-2025

Historic Other Non Operating Income for CG Oncology (CGON) over the last 3 years, with Sep 2025 value amounting to -$100,000.

  • CG Oncology's Other Non Operating Income fell 4900.00% to -$100,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$93,000, marking a year-over-year decrease of 1228.57%. This contributed to the annual value of $3,000 for FY2024, which is 104.84% up from last year.
  • As of Q3 2025, CG Oncology's Other Non Operating Income stood at -$100,000, which was down 2,400.00% from -$4,000 recorded in Q2 2025.
  • In the past 5 years, CG Oncology's Other Non Operating Income ranged from a high of $8,000 in Q1 2023 and a low of -$100,000 during Q3 2025.
  • Its 3-year average for Other Non Operating Income is -$14,364, with a median of -$4,000 in 2025.
  • Its Other Non Operating Income has fluctuated over the past 5 years, first spiked by 250.00% in 2024, then tumbled by 4,900.00% in 2025.
  • Over the past 3 years, CG Oncology's Other Non Operating Income (Quarterly) stood at -$4,000 in 2023, then spiked by 250.00% to $6,000 in 2024, then crashed by 4,900.00% to -$100,000 in 2025.
  • Its Other Non Operating Income was -$100,000 in Q3 2025, compared to -$4,000 in Q2 2025 and $5,000 in Q1 2025.